Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses

American Journal of Public Health

Volumn 86, Issue 5, 1996, Pages 655-661

  Garfein, Richard S ^a   Vlahov, David ^a   Galai, Noya ^a   Doherty, Meg C ^a   Nelson, Kenrad E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG;

ADULT; ARTICLE; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SERODIAGNOSIS; SEXUAL BEHAVIOR;

EID: 0029867968     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.86.5.655     Document Type: Article

References (24)

1. Esteban R. Epidemiology of hepatitis C virus infection. J Hepatol. 1993;17(S-3):S67-S71.
2. Levine OS, Vlahov D, Nelson KE. Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev. 1994;16:418-436.
3. Des Jarlais DC, Friedman SR, Choopanya K, Vanichseni S, Ward TP. International epidemiology of HIV and AIDS among injecting drug users. AIDS. 1992;6:1053-1068.
4. Manns A, Blattner WA. The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease. Transfusion. 1991;31:67-75.
5. Friedman SR, Des Jarlais DC, Neaigus A, et al. AIDS and the new drug injector. Nature. 1989;339:333-334.
6. Levine OS, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injection drug users: association with drug injection patterns. Am J Epidemiol. 1995; 142:331-341.
7. Alter M. The detection, transmission, and outcome of hepatitis C virus infection. Infect Agents Dis. 1993;2:155-166.
8. Robert-Guroff M, Weiss SH, Giron JA, et al. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA. 1986;255:3133-3137.
9. van den Hoek JAR, Coutinho RA, van Hasstrecht HJA, van Zadelhoff AW, Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drugusing prostitutes in Amsterdam. AIDS. 1988;2:55-60.
10. Zeldis JB, Jain S, Kuramoto IK, et al. Seroepidemiology of viral infections among intravenous drug users in Northern California. West J Med. 1992;156:30-35.
11. Bell J, Batey RG, Garrell GC, Crewe EB, Cunningham AL, Byth K. Hepatitis C virus in intravenous drug users. Med J Aust. 1990;153:274-276.
12. Nicolosi A, Leite MLC, Musicco M, Molinari S, Lazzarin A. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. Am J Epidemiol. 1992;135:225-233.
13. Nelson KE, Vlahov D, Solomon L, Conn S, Muñoz A. Temporal trends of incident HIV infection in a cohort of injection drug users in Baltimore, Maryland. Arch Intern Med. 1995;155:1305-1311.
14. van den Hoek JAR, van Haastrecht HJA, Goudsmit J, de Wolf F, Coutinho RA. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis. 1990;162:823-826.
15. Donahue JG, Nelson KE, Muñoz A, et al. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol. 1991;134:1206-1211.
16. Vlahov D, Anthony JC, Muñoz A, et al. The ALIVE study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J Drug Issues. 1991;21:759-776.
17. Hser Y, Anglin MD, McGlothlin W. Sex differences in addict careers, 1 : initiation of use. Am J Drug Alcohol Abuse. 1987;13:33-57.
18. Gleghorn AA, Doherty MC, Vlahov D, Celentano DD, Jones TS. Inadequate bleach contact times during syringe cleaning among injection drug users. J Acquir Immune Defic Syndr. 1994;7:767-772.
19. Fliess JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley and Sons; 1981.
20. Breslow NE, Day NE. Unconditional logistic regression for large strata. In: Statistical Methods in Cancer Research, Vol 1: The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer; 1980:191-246.
21. Vlahov D, Khabbaz RF, Cohn S, Galai N, Taylor E, Kaplan JE. Incidence and risk factors for human T-lymphotrophic virus, type II (HTLV-II) seroconversion among injecting drug users in Baltimore, Maryland. J Acquir Immune Defic Syndr. 1995;9:89-96.
22. van Ameijden EJC, van den Hoek JAR, Mientjes GHC, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV, and HCV infection among drug users in Amsterdam. Eur J Epidemiol. 1993;9:255-262.
23. Chaisson RE, Bacchetti P, Osmond D, et al. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989;261:561-565.
24. Wiktor SZ, Cannon RO, Atkinson WL, et al. Infection with human T lymphotrophic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. J Infect Dis. 1992;165:920-924.